SOURCE: Xtalks

Xtalks Webinars

August 23, 2016 07:00 ET

Drug Safety in a Start Up Biotech, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - August 23, 2016) - In this webinar, industry expert Ed Tucker, Senior Vice President for Medical Safety, Quality and Compliance from Acerta (a majority owned company of AstraZeneca) will illustrate specific start-up needs, including how to mitigate inherent risks and lay out foundational principles to creating a medical safety group to meet the evolutionary steps of a startup biopharma company. There will be two live broadcasts on Thursday, September 15, 2016 at 10am EDT (3pm BST/UK) and 3pm EDT.

When and how should a biopharma start-up consider establishing their own Medical Safety group? The opportunities and challenges differ greatly between an emerging biopharma company and a fully established entity. A start-up needs to assess the priorities of the company, the stage of development, the talents and resources available while building for success into submission, approval and through to commercialization.

Join Dr. Ed Tucker as he takes the audience along this journey with lessons learnt from both an organizational and personal perspectives.

For more information or to register for this complimentary event, visit: Drug Safety in a Start Up Biotech

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Image Available:

Contact Information